This program is sold out.
Call us at (202) 633-3030 to get on the Wait List.
Don’t miss out on future programs like this.
As a Smithsonian Associates member
, you will receive ticket-buying priority.
The Science of CBD: Anecdotes and Evidence
Thursday, February 20, 2020 - 6:45 p.m.
Of the more than 100 related chemicals found in cannabis plants, cannabidiol (CBD) has become almost as well-known as tetrahydrocannabinol (THC), seemingly overnight. Now widely available in retail stores and websites, it has suddenly emerged as a popular consumer product.
But it has been difficult to demonstrate exactly what CBD does. It neither produces a high like THC, nor does it have the same biological actions. And although promoted as a remedy for a wide variety of conditions, only one CBD product has received FDA approval—for the treatment of a specific type of severe childhood epilepsy.
Much remains unknown about the effects, mechanism, long-term consequences and legality of CBD. Join Steven Grant, a neuroscientist at the National Institutes of Health, for an examination of what research has—and more importantly, has not—discovered about this elusive chemical's potential benefits and risks.
S. Dillon Ripley Center
1100 Jefferson Dr SW
Metro: Smithsonian (Mall exit)